A Day Up For Bluejay Diagnostics Inc.
Thu, Dec 05, 2024 at 07:33 PM
Bluejay Diagnostics Inc. (BJDX:NASDAQ) rocketted at $6.2, a gain of 59.4%. On Thu, Dec 05, 2024, BJDX:NASDAQ hit a New 2-Week High of $6.2. The stock got featured on our News Catalysts scanner on Wed, Nov 13, 2024 at 06:54 PM in the 'SPLIT' category. From Fri, Nov 22, 2024, the stock recorded 75.00% Up Days and 44.44% Green Days
The stock spiked on Tue, Nov 05, 2024 at $12.45 with a volume of 15M+.
About Bluejay Diagnostics Inc. (BJDX:NASDAQ)
Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide...
Top 10 Gainers:
- Oriental Rise Holdings Limited (ORIS:NASDAQ), 599.25%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 93.95%
- ArTara Therapeutics, Inc. (TARA:NASDAQ), 70.06%
- PainReform Ltd. (PRFX:NASDAQ), 67.91%
- CalAmp Corp. (CAMP:NASDAQ), 65.99%
- Molecular Templates, Inc. (MTEM:NASDAQ), 60.26%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 59.38%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 56.05%
- Foxx Development Holdings Inc. (FOXX:NASDAQ), 54.69%
- SRIVARU Holding Limited (SVMH:NASDAQ), 48.94%